ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says

November 10, 1989

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004

USPSTF’s Michael LeFevre: Lung Screening Can Save More Lives With Fewer Screens Than Mammography

August 2, 2013

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

Clinical Trials Approved By NCI CTEP Last Month

December 31, 2010

PRI Drops Suit Against Top Two FCRF Staff; Gilden, Compton Accept “Partnership” Offers

August 22, 1986